Skip to content
Search

Latest Stories

GPhC appoints Gisela Abbam as its new chair

General Pharmaceutical Council (GPhC) has appointed Gisela Abbam as its new chair.

Appointment of Abbam, who will assume office on March 14, 2022, was made by the Privy Council after a robust selection process which was scrutinised by the Professional Standards Authority.


She will take over from the current chair, Nigel Clarke, who has been in position since 2014 and has completed the statutory maximum eight years in office.

Commenting on her appointment, Abbam said: "I am delighted and honoured to be appointed as the new chair of the General Pharmaceutical Council and I look forward to leading the Council to achieve its vision of safe and effective pharmacy care at the heart of healthier communities.

“Covid-19 highlighted the increased role of pharmacists, pharmacy technicians and pharmacies in providing clinical services. Effective standards and regulation can help pharmacy to provide more support to patients and the public at large. I look forward to working with Council, the Executive team and staff and collaborating with other organisations to improve the health of people using pharmacy services."

Welcoming Abbam to the Council, Clarke, said: “Gisela is joining the GPhC at an exciting time of major changes in both pharmacy and health regulation. I am sure her vast experience in healthcare will help the GPhC drive forward the aims set out in our Vision 2030, and bring a real focus on the difference we want to make for patients and the public.”

Previously, Abbam was chair of the British Science Association (BSA). During her tenure, she led the BSA’s Council and championed the BSA mission and vision, driving forward an agenda on equality, diversity, and inclusion in STEM (Science, Technology, Engineering and Maths).

She has worked in collaboration with governments, the World Health Organisation, the United Nations, and other multilateral organisations to improve health outcomes for people across the world.

She is also the senior director government affairs for EMEAI at PerkinElmer, a global provider of end-to-end solutions that help scientists, researchers and clinicians better diagnose disease, discover new and more personalised drugs, monitor the safety and quality of food.

Besides, she serves on a number of advisory committees and sits on the Board of Everywoman Ltd., an organisation dedicated to advancing women in business.

Many in the industry congratulated the Council on the new appointment.

Welcoming the new GPhC chair, Mark Lyonette, chief executive of National Pharmacy Association wrote on twitter, “looking forward to meeting @gmabbam once she starts.

Mark tweet

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less